NCT06724406 · University of North Carolina, Chapel Hill
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
(FAM WEL B-ing)
What this study is about
The goal of this clinical trial is to learn the best combination of family components that yields optimal weight loss among Black adults.
View original scientific description
The goal of this clinical trial is to learn the best combination of family components that yields optimal weight loss among Black adults. The main question it aims to answer is: What combination of four family components in combination with a standard behavioral weight loss program yields optimal weight loss among Black adults? Researchers will compare different combinations of family skills components (communication content, cohesion content, number of sessions, and mode of delivery) to see the best weight loss.
Interventions
BEHAVIORAL
Family Skills Training Session Quantity: 5
The number of family skills training sessions administered: 5 sessions
BEHAVIORAL
Family Skills Training Session Mode: In-person
The mode of administration of family skills training sessions: in person or online
BEHAVIORAL
Family Skills Training Content: Communication
The content of family skills training sessions administered focused on communication and conflict resolution : communication and conflict resolution
BEHAVIORAL
Family Skills Training Content: Cohesion
The content of family skills training sessions administered focused on cohesion: cohesion or no cohesion
BEHAVIORAL
Family Skills Training Session Quantity: 10
The number of family skills training sessions administered: 10 sessions
BEHAVIORAL
Family Skills Training Session Mode: Online
The mode of administration of family skills training sessions: online
BEHAVIORAL
Family Skills Training Content: No Communication
The content of family skills training sessions administered focused on communication and conflict resolution : no communication and conflict resolution
BEHAVIORAL
Family Skills Training Content: No Cohesion
The content of family skills training sessions administered focused on cohesion: no cohesion
Primary outcome measures
Change in Body weight
Time frame: baseline and 6 months
Body weight (kg) expressed as a continuous variable will be collected on a digital scale.
Who can participate
This study lists these criteria on ClinicalTrials.gov. A study coordinator reviews eligibility during screening — this page does not determine whether you qualify.
Inclusion criteria
- self-identified as Black or African American (Index participant)
- BMI equal to greater than 30 kg/m\^2 (Index); BMI equal to greater than 27.5 kg/m\^2 (family partner)
- have a partner/family member willing to enroll in the study and must share a mutual goal of achieving weight loss
- English speaking
- have access to and be able to use a smartphone, tablet, or computer that has web-access (this is required for data collection and some program components being tested)
Exclusion criteria
- participation in an intensive weight loss program (more than 12 visits) in the prior 6 months
- type 1 diabetes
- significant psychiatric illness, defined as depression or other major psychiatric illness not considered reasonably managed by counseling, medication, or both
- had bariatric surgery (surgery for weight loss) in the last 2 years or considering bariatric surgery in the next 6 months
- using or planning to start medications intentionally for weight loss
- are pregnant or planning to get pregnant in the next 6 months
- are breastfeeding and less than 2 months postpartum
- alcohol or substance abuse, defined as alcohol or substance use that interferes with work activities and/or has had a major negative impact on family/social function, the latter defined as more than 2 episodes per month.
- malignancy other than non-melanoma skin cancer, unless considered cured \> 5 years ago. Exceptions include 1) men with localized prostate cancer (treated with usual modalities or managed with "active surveillance"), and 2) postmenopausal women receiving adjuvant endocrine therapy (e.g., aromatase inhibitor) for non-metastatic, hormone receptor-positive breast cancer
- self-report of advanced kidney disease (estimated glomerular filtration rate (GFR) \< 30 mL/min)
Where
- Chapel Hill, North Carolina
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Related conditions & keywords
Frequently asked questions
What is a clinical trial?
A clinical trial is a research study that tests new medical treatments, drugs, devices, or procedures to determine their safety and effectiveness. Trials are carefully designed and monitored to protect participants while advancing medical knowledge.
Is it safe to participate?
Clinical trials follow strict safety guidelines and ethical standards. Trials must be reviewed and approved, and participants are closely monitored by medical professionals throughout the study. You can withdraw at any time if you choose.
Will I be compensated?
Many clinical trials offer compensation for your time, travel expenses, and inconvenience. The specific compensation varies by study and will be discussed during the screening process. All study-related medical care is typically provided at no cost to participants.
Will I receive a placebo instead of treatment?
When effective treatment exists, participants typically receive either the standard treatment plus the study intervention, or the standard treatment plus placebo. You would not be denied effective care. Placebos are primarily used when no proven treatment is available, or in addition to standard care. Your trial consent form will clearly explain what treatments you may receive.
Can I leave a trial if I change my mind?
Absolutely. Participation in clinical trials is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty or loss of benefits to which you are otherwise entitled.
How long does a clinical trial last?
Trial duration varies widely depending on the study design and purpose. Some trials last just a few weeks, while others may continue for months or years. The study coordinator will provide specific timeline information during your screening call.
Data: ClinicalTrials.gov · synced Aug 29, 2025 · Source of record for eligibility and locations